Ellis Andrea
- SEC CIK
- 0001877680
In the past year, 2 open-market sale filings worth $5.65M and no purchases.
Current role at each company
- BBIO BridgeBio Pharma, Inc.Directoras of Jul 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.65M
- 2 filings
- Net
- −$5.65M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ellis Andrea as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 (view filing)4:41 PM ET | Jul 9 | 4 days | Ellis AndreaDirector | SSale | −17.2K | $84.00 | −$1.44M | −43.2%22.6K after | 10b5-1 |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Ellis AndreaDirector | SSale | −64.9K | $64.87 | −$4.21M | −77.7%18.6K after | 10b5-1 |
| Aug 7, 2025 (view filing) | Aug 5 | 2 days | Ellis AndreaDirector | SSale | −17.2K | $49.00 | −$841.2K | −48.0%18.6K after | 10b5-1 |
| Apr 16, 2025 (view filing) | Apr 14 | 2 days | Ellis AndreaDirector | SSale | −10.0K | $35.00 | −$350.0K | −45.5%12.0K after | 10b5-1 |
| Apr 3, 2025 (view filing) | Apr 1 | 2 days | Ellis AndreaDirector | SSale | −30.0K | $34.05 | −$1.02M | −71.4%12.0K after | 10b5-1 |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Ellis AndreaDirector | PPurchase | +12.0K | $8.39 | +$100.7K | New position12.0K after |